Developing those people who will lead tomorrow’s companies and not-for-profit organisations has never been more important, according the Resonate Consulting in the lead up to the Asia Pacific Pro Bono Summit in Sydney in November.
Within this context, pro bono is emerging as an innovative, high-impact strategy that can equip corporate leaders with the skills they will need to thrive.
Companies are no longer asking “should we engage in the community” but “HOW?”. Studies are showing that corporate giving is critical to attracting and retaining top …
Ever wondered how technology can be used to achieve a greater good? Join thought-leaders, change-makers and technology experts for the Tech and Digital Disruption for Purpose free event in Melbourne on 24 October to explore new intersections between tech and the not-for-profit sector.
Staying ahead of the innovation curve and being able to predict the future of tech and how this can serve the not-for-profit or for purpose sector has never been more important, according to Ingrid Josephine, partnerships and events manager at educational institution, General …
Adam Jahnke is the co-founder and CEO of Umps Health which uses smart technology to support older people and their care providers. He is One to Watch.
A total of 60 of Australia’s brightest young changemakers have been selected by the Foundation for Young Australians (FYA) to take part in the 2017 Young Social Pioneers (YSP) program. It is Australia’s first, and only, national youth entrepreneurship incubator designed exclusively for young people leading initiatives that respond to society’s most pressing challenges. In this mini-series Pro Bono …
Professor Andreas Obermair is a Brisbane-based gynaecological oncologist and co-founder of the Cherish Women’s Cancer Foundation, which raises funds for gynaecological cancers. He is this week’s Changemaker.
Obermair grew up in Austria, and since moving to Australia in 1999, he has become one of the country’s leading gynaecological cancer specialists.
In January 2012, he founded the Cherish Women’s Cancer Foundation, which generates funding for research and clinical trials so that they can “find kinder ways to treat women with gynaecological cancer”.